Сlinical, functional and morphological results of diabetic macular edema antiangiogenic treatment in patients with diabetes mellitus type two
Purpose: To evaluate of retinal morphology and function progress in patients with diabetes type 2 and DME consistent with the level of pathogenetic factor in tear fluid.Methods: The progress of visual acuity, retinal thickness and photosensitivity after ranibizumab intravitreal injection has been as...
Saved in:
| Main Authors: | L. K. Moshetova, I. V. Vorobieva, E. V. Parfenova, D. A. Merkushenkova, P. I. Makarevich, V. I. Alekhnovich |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2014-07-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/54 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diabetic retinopathy in type two diabetic patients: Epidemiology and modern view on the pathogenesis. Review
by: I. V. Vorobieva, et al.
Published: (2014-07-01) -
The results of comparative analysis of angiogenic and laser therapy for diabetic macular edema in diabetes type 2
by: I. V. Vorobieva, et al.
Published: (2014-07-01) -
Clinical efficacy of antiangiogenic therapy for diabetic macular edema in real clinical practice (2-year results)
by: A. Zh. Fursova, et al.
Published: (2021-06-01) -
Real-World Data on Morphological and Functional Responses After Switching to Faricimab in Recalcitrant, Chronic Diabetic Macular Edema
by: Viktoria Deiters, et al.
Published: (2025-05-01) -
Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study
by: Chakraborty D, et al.
Published: (2024-11-01)